LegalMay 29, 2026, 07:01 AM
Seer Files ITC Complaint Against Nanomics for Patent Infringement
AI Summary
Seer, Inc. announced it has filed a complaint with the United States International Trade Commission (ITC) against Nanomics Biotechnology Co., Ltd., with Brigham and Women's Hospital joining the action. The complaint alleges infringement of five U.S. patents related to nanoparticle protein enrichment, building on a prior federal district court suit. Seer seeks an investigation and an exclusion order to prevent Nanomics' Proteonano kits and workstations from entering the U.S., emphasizing its commitment to protecting its pioneering technology and product integrity.
Key Highlights
- Seer filed an ITC complaint against Nanomics Biotechnology Co., Ltd.
- Brigham and Women's Hospital joined the ITC complaint.
- Complaint alleges infringement of U.S. Patent Nos. 11,435,360, 11,630,112, 12,050,222, 12,228,566, and 12,590,948.
- Patents protect Seer's intellectual property in nanoparticle protein enrichment.
- Seer seeks an exclusion order barring Nanomics' Proteonano kits and workstations from the U.S.
- The ITC complaint follows a federal district court patent infringement suit filed on May 12, 2026.
Price Impact
More from SEER